Management of Patients With Glucocorticoid-Related Diseases and COVID-19
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting millions of people worldwide. SARS-CoV-2 enters the host cells by binding to angiotensin-converting enzyme 2 (ACE2) after bein...
Main Authors: | Irina Chifu, Mario Detomas, Ulrich Dischinger, Otilia Kimpel, Felix Megerle, Stefanie Hahner, Martin Fassnacht, Barbara Altieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.705214/full |
Similar Items
-
Bilateral Adrenocortical Masses Producing Aldosterone and Cortisol Independently
by: Seung-Eun Lee, et al.
Published: (2015-12-01) -
Secondary hyperaldosteronism leading to resistant hypertension in a patient with adrenal Cushing’s syndrome
by: I. Ranathunga, et al.
Published: (2020-08-01) -
Glucocorticoid Withdrawal—An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice
by: Katarzyna Pelewicz, et al.
Published: (2021-04-01) -
Unilateral nodular adrenal hyperplasia: Case series
by: A.F. Kotb, et al.
Published: (2016-09-01) -
Oral pathology induced by excess or deficiency of glucocorticoids in adults
by: Rucsandra Elena Dănciulescu Miulescu, et al.
Published: (2020-10-01)